312 related articles for article (PubMed ID: 22324547)
1. Prevalence of metabolic syndrome components among the elderly using three different definitions: a cohort study in Finland.
Saukkonen T; Jokelainen J; Timonen M; Cederberg H; Laakso M; Härkönen P; Keinänen-Kiukaanniemi S; Rajala U
Scand J Prim Health Care; 2012 Mar; 30(1):29-34. PubMed ID: 22324547
[TBL] [Abstract][Full Text] [Related]
2. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
Sirdah MM; Abu Ghali AS; Al Laham NA
Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Metabolic Syndrome among Malaysians using the International Diabetes Federation, National Cholesterol Education Program and Modified World Health Organization Definitions.
Bee YT; Haresh KK; Rajibans S
Malays J Nutr; 2008 Mar; 14(1):65-77. PubMed ID: 22691765
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome among overweight and obese adults in Palestinian refugee camps.
Damiri B; Abualsoud MS; Samara AM; Salameh SK
Diabetol Metab Syndr; 2018; 10():34. PubMed ID: 29713387
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
[TBL] [Abstract][Full Text] [Related]
7. Comparison of metabolic syndrome prevalence using four different definitions - a population-based study in Finland.
Haverinen E; Paalanen L; Palmieri L; Padron-Monedero A; Noguer-Zambrano I; Sarmiento Suárez R; Tolonen H;
Arch Public Health; 2021 Dec; 79(1):231. PubMed ID: 34949223
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of different waist circumference cut-off values in predicting metabolic syndrome prevalence and risk factors in adults in China.
Zhou HC; Lai YX; Shan ZY; Jia WP; Yang WY; Lu JM; Weng JP; Ji LN; Liu J; Tian HM; Ji QH; Zhu DL; Chen L; Guo XH; Zhao ZG; Li Q; Zhou ZG; Ge JP; Shan GL
Biomed Environ Sci; 2014 May; 27(5):325-34. PubMed ID: 24827713
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India.
Yadav D; Mahajan S; Subramanian SK; Bisen PS; Chung CH; Prasad GB
Glob J Health Sci; 2013 Sep; 5(6):142-55. PubMed ID: 24171882
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population.
He Y; Jiang B; Wang J; Feng K; Chang Q; Fan L; Li X; Hu FB
J Am Coll Cardiol; 2006 Apr; 47(8):1588-94. PubMed ID: 16630995
[TBL] [Abstract][Full Text] [Related]
11. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
Nilsson PM; Engström G; Hedblad B
Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
[TBL] [Abstract][Full Text] [Related]
12. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.
Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
PLoS One; 2014; 9(9):e107294. PubMed ID: 25244618
[TBL] [Abstract][Full Text] [Related]
13. Comparing the association of two metabolic syndrome definitions, NCEP ATP III and IDF, with the risk of developing atherosclerotic cardiovascular disease: An analytical cross-sectional study.
Yousefzadeh G; Sayyadi A; Najafipour H; Sabaghnejad V; Pezeshki S
Endocrinol Diabetes Metab; 2024 Jan; 7(1):e468. PubMed ID: 38268305
[TBL] [Abstract][Full Text] [Related]
14. National Cholesterol Educational Program and International Diabetes Federation diagnostic criteria for metabolic syndrome in an Italian cohort: results from the FIBAR Study.
Mannucci E; Monami M; Bardini G; Ognibene A; Rotella CM
J Endocrinol Invest; 2007 Dec; 30(11):925-30. PubMed ID: 18250613
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study.
Sidorenkov O; Nilssen O; Brenn T; Martiushov S; Arkhipovsky VL; Grjibovski AM
BMC Public Health; 2010 Jan; 10():23. PubMed ID: 20085638
[TBL] [Abstract][Full Text] [Related]
16. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China.
Zhou J; Gao Q; Wang J; Zhang M; Ma J; Wang C; Chen H; Peng X; Hao L
BMJ Open; 2018 Oct; 8(10):e022974. PubMed ID: 30366915
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of undiagnosed metabolic syndrome using three different definitions and identifying associated risk factors among apparently healthy adults in Karachi, Pakistan: a cross-sectional survey in the year 2022.
Adil SO; Musa KI; Uddin F; Khan A; Khan I; Shakeel A; Shafique K; Islam MA
Arch Public Health; 2024 Feb; 82(1):22. PubMed ID: 38378657
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program.
Yayıcı Köken Ö; Kara C; Can Yılmaz G; Aydın HM
J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):55-62. PubMed ID: 31434460
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome in Gwalior region of Central India: A comparative study using NCEP ATP III, IDF and Harmonized criteria.
Subramani SK; Mahajan S; Chauhan P; Yadav D; Mishra M; Pakkirisamy U; Prasad GBKS
Diabetes Metab Syndr; 2019; 13(1):816-821. PubMed ID: 30641814
[TBL] [Abstract][Full Text] [Related]
20. A comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction.
Corona G; Mannucci E; Petrone L; Schulman C; Balercia G; Fisher AD; Chiarini V; Forti G; Maggi M
J Sex Med; 2007 May; 4(3):789-796. PubMed ID: 17498109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
